All the news Showing 10 of 696 articles from: Treatment issuesGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Ultra-short course treatment for hepatitis C: high failure rate but does not compromise second-line treatment Keith Alcorn / 13 September 2021 Ultra-short treatment courses tailored to a person's pre-treatment viral load deliver lower cure rates than 8-week treatment courses, but failure of ultra-short treatment does not prevent subsequent cure of hepatitis ... Short stay in prison increases the risk of hepatitis C for people who use drugs Keith Alcorn / 03 September 2021 People who use drugs were over 50% more likely to acquire hepatitis C between 2004 and 2019 if they spent even a brief period in prison, a prospective study carried out in ... Japanese study shows benefits of treating hepatitis C early Keith Alcorn / 24 August 2021 Curing hepatitis C in people with mild fibrosis by the age of 50 reduces their risk of death to the same level as the rest of the population, Japanese researchers report in ... High hepatitis C cure rate in Thai study of community-based treatment Keith Alcorn / 09 August 2021 Community-based testing and treatment for HIV and hepatitis C achieved high hepatitis C cure rates in Thailand, results from the Thai C-FREE study show. Tanyapom Wansom presented results from the C-FREE cohort study of ... Peer support improved hepatitis C treatment uptake and completion in England Keith Alcorn / 30 June 2021 Peer support increased hepatitis C treatment initiation and completion in England between 2017 and 2020, an evaluation of a national peer support scheme run by the Hepatitis C Trust has found. ... FDA approves oral pellet version of Gilead's Epclusa for use in young hepatitis C patients Fierce Pharma / 21 June 2021 HIV treatment choice affects improvement in liver after hepatitis C cure Keith Alcorn / 08 June 2021 People with HIV who were cured of hepatitis C experienced greater reductions in liver stiffness if they were taking an antiretroviral regimen that contained a non-nucleoside reverse transcriptase inhibitor (NNRTI), Spanish researchers report ... New Report Shows Discriminatory Sobriety Restrictions Undermine Public Health Efforts to Eliminate Hepatitis C National Viral Hepatitis Roundtable / 21 May 2021 More People Who Inject Drugs Are Being Treated for Hepatitis C Hep Magazine / 21 May 2021 Liver function improves in most people with cirrhosis after hepatitis C cure Keith Alcorn / 18 May 2021 Most people with hepatitis C and liver cirrhosis experience improvement in liver function after direct-acting antiviral treatment, but a small minority – mainly those with a history of liver decompensation – may ... ← Prev1...23456...70Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Transmission and prevention Diagnosis and monitoring Disease course and symptoms HCV and coinfections Living with HCV Treatment issues Side effects Therapies Liver transplants Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Email bulletin archive